Because he makes me laugh out loud with posts like this:
No, I'm not going to spoil the fun - go and check out his story here.
« links for 2010-02-04 | Main | Why did Roche's Avastin lose steam in 4th quarter 2009? »
February 05, 2010
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8342ae08153ef0120a866148d970b
Listed below are links to weblogs that reference Why I read PharmaGossip on Fridays:
The comments to this entry are closed.
Publisher
- This blog is published by:
Sally Church, PhD
of Icarus Consultants, Inc.
The contents of this blog are the intellectual property of the author and all rights are reserved. No commercial use, copying or distribution is permitted without the author's express permission.
Become a Fan
What we do
Icarus Consultants is a management consulting company focusing on marketing strategy and new product development to the Pharma and Biotech industry. We focus on specialist areas such as oncology, hematology, immunology, respiratory and HIV.
Our particular areas of interest include social media monitoring, key opinion leader research, competitive intelligence and landscape opportunity assessments. We use primary qualitative market research and buzz metrics to support our strategic analyses.
Company Web Site
Follow Me
Pharma Twitter Groups
Stat Counter
Recent Comments
- Ruby Gadelrab on Pathwork Diagnostics and Novartis to pursue a research partnership
- MaverickNY on The ravages of smoking and cancer...
- Dave Hodgkinson on The ravages of smoking and cancer...
- Gregory Pawelski on Time for FDA and ODAC to decide on Avastin in breast cancer
- Gregory Pawelski on The Long Tail of Cancer Research
- MaverickNY on Simplifying data capture and blog post workflow
- Drmiggy on Monday Mumblings - Life in the fast lane
- Drpdtapp on On clinical trials, creativity and patient adherence in cancer
- twitter.com/jodyms on On clinical trials, creativity and patient adherence in cancer
- CraigLipset on On clinical trials, creativity and patient adherence in cancer
Comments